Want to invest in Biogen (BIIB)?
Thought about investing and weren't sure where to start? We are here to help you sign up free with eToro
and start trading using either real or virtual funds with one of the leading trading platforms in the world. Offering a range of features as well as a focus on the social aspect of trading, there is no obligation to make a deposit and the eToro community helps make it easy for anyone to learn to trade or better their trading skills. There are also apps available for popular mobile devices if you prefer to trade whilst on the go, at work or on holiday. You can practice trading using virtual money and no risk before making a deposit to see if it suits you. Promotions are often available and if you refer friends who make a deposit you can earn extra credit to trade with.
Biogen, Inc. (previously known as Biogen Idec) is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases to patients worldwide. In January 2015 the company announced it will acquire Convergence Pharmaceuticals for up to $675 million, with the acquisition aiming to accelerate the development of Convergence's pipeline, in-particular CNV1014802 - a Phase II small molecule sodium channel blocking candidate. In October 2015 the company announced it will lay off 11% of its workforce, effective immediately. - Wikipedia - 10/2016